FDA Panel Recommends Against Wider Use of Zimmer’s Dynesys Spinal System

An FDA advisory panel of medical experts has recommended against proposed wider use of Zimmer’s Dynesys spine stabilization device, according to a report by Reuters.

Advertisement

Zimmer is asking for stand-alone use of Dynesys, a series of screws and flexible spacers that aim to help align and support the spine, which is already approved for use in patients with back problems who undergo surgical fusion.

Panel members questioned how the device would hold up over time and expressed concern about possible breakage, but they added that the device holds promise.

Read Reuters’ report on Zimmer’s Dynesys spinal device.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.